Also, closely connected cancer types share the same medication, e.g., Skin cancer and Melanoma are treated by Vemurafenib and Dabrafenib which are enzyme inhibitor of BRAF gene [57], Leukemia and Non-Hodgkin lymphoma are treated by the antibody Rituximab targeting B-lymphocyte antigen CD20 [58]. This evidence concerns the gene AKAP17A and melanoma.